NCT02412488

Reveal LINQ™ In-Office 2 (RIO2) Study International

Reveal LINQ™ In-Office 2 (RIO2) International Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 191 (actual)
• Sponsor: Medtronic Cardiac Rhythm and Heart Failure · Industry
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the RIO 2 International study is to provide clinical and economic evidence to support moving the LINQ™ insertion procedure outside these traditional locations within the hospital, referred to as "out-of-cathlab".

Detailed description

The traditional location of the LINQ™ insertion procedure is the catheterization laboratory, electrophysiology laboratory, or operating room. The purpose of the RIO 2 International study is to provide clinical and economic evidence to support moving the LINQ™ insertion procedure outside these traditional locations within the hospital, referred to as "out-of-cathlab".

Conditions

• Arrhythmia

Interventions

Type	Name	Description
OTHER	Out of cathlab insertion	Insertion of the Reveal LINQ device in the "out-of-cathlab" setting (out of the operating room, cardiac catheterization or electrophysiology laboratory).

Timeline

• Start date: 2015-02-01
• Primary completion: 2016-09-22
• Completion: 2016-10-20
• First posted: 2015-04-09
• Last updated: 2019-02-11
• Results posted: 2019-02-11